3Niederman MS, Mandell LA, Aniueto A, et al. Guideline for the management of adult with community-acquired pneumonia, diagnosis, assessment of severity, antimicrobial therapy and prevention. Am J Respir Crit Care Med, 2001, 163 : 1730 - 1754.
9Pfaller MA, Jones RN. Antimicmbial susceptibility of inducible AmpC β-lactamase-producing enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000. Int J Antimicrob Agents, 2002, 19:383-388.
6[4]Hirakata Y, Izumikawa K, Yamaguchi K, et al.Rapid detection and evolution of clinical characteristics of emerging multiple-drug-resistant Gram-negative rods carrying the metallo-β-lactamase gene blaIMP[J]. Antimicrob Agents Chemother, 1998, 42: 2006-2011.
7[5]Arakawa Y, Shibata N, Shibayama K, et al. Convenient test for screening metallo-β-lactamase-producing Gram-negative bacteria by using thiol compounds[J]. J Clin Microbiol, 2000, 38(1): 40-43.
8[6]National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard[S]. Fifth edition. Wayne Pennsylvania National Committee for Clinical Laboratory Standards. 2001.
9[7]Saino Y, Kobayash F, Inoue M, et al. Purification and properties of inducible penicillin-beta-lactamase isolates from Pseudomonas maltophilia[J]. Antimicrob Agents Chemother, 1982, 22: 564-570.
10[8]Senda K, Arakawa Y, Nakashima K, et al. Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems[J]. Antimicrob Agents Chemother, 1996, 40(2): 349-353.
9Sievert DM, Rudrik JT, Patel JB, et al. Vancomycin resistant Staphylococcusaureus in the United States 2002-2006[J].Clin Infect D, 2008,46(5):668-674.
